- Home
- AVXL vs RWT Comparison
AVXL vs RWT Comparison
Compare AVXL & RWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVXL
- RWT
- Stock Information
- Founded
- AVXL 2004
- RWT 1994
- Country
- AVXL United States
- RWT United States
- Employees
- AVXL N/A
- RWT N/A
- Industry
- AVXL Biotechnology: Biological Products (No Diagnostic Substances)
- RWT Real Estate Investment Trusts
- Sector
- AVXL Health Care
- RWT Real Estate
- Exchange
- AVXL Nasdaq
- RWT Nasdaq
- Market Cap
- AVXL 757.9M
- RWT 678.2M
- IPO Year
- AVXL N/A
- RWT 1995
- Fundamental
- Price
- AVXL $8.37
- RWT $6.02
- Analyst Decision
- AVXL Strong Buy
- RWT Buy
- Analyst Count
- AVXL 2
- RWT 11
- Target Price
- AVXL $44.00
- RWT $7.59
- AVG Volume (30 Days)
- AVXL 703.8K
- RWT 921.8K
- Earning Date
- AVXL 05-13-2025
- RWT 04-30-2025
- Dividend Yield
- AVXL N/A
- RWT 11.44%
- EPS Growth
- AVXL N/A
- RWT 105.35
- EPS
- AVXL N/A
- RWT 0.21
- Revenue
- AVXL N/A
- RWT $241,796,000.00
- Revenue This Year
- AVXL N/A
- RWT N/A
- Revenue Next Year
- AVXL N/A
- RWT $0.46
- P/E Ratio
- AVXL N/A
- RWT $28.59
- Revenue Growth
- AVXL N/A
- RWT 29.94
- 52 Week Low
- AVXL $3.51
- RWT $4.68
- 52 Week High
- AVXL $14.44
- RWT $8.15
- Technical
- Relative Strength Index (RSI)
- AVXL 44.23
- RWT 55.24
- Support Level
- AVXL $7.98
- RWT $5.85
- Resistance Level
- AVXL $8.68
- RWT $6.01
- Average True Range (ATR)
- AVXL 0.41
- RWT 0.15
- MACD
- AVXL -0.08
- RWT 0.02
- Stochastic Oscillator
- AVXL 23.31
- RWT 47.96
About AVXL Anavex Life Sciences Corp.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.
About RWT Redwood Trust Inc.
Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: Sequoia Mortgage Banking includes mortgage loan conduit that acquires residential consumer loans from third-party originators for sale to whole loan buyers and securitization; CoreVest Mortgage Banking segment includes consists of a platform that originates residential investor loans for securitization, sale, or transfer into Redwood Investments portfolio; and Redwood Investments segment consists of organic investments sourced through mortgage banking operations, including securities retained from Sequoia and CoreVest securitization activities. It derives maximum revenue from Redwood Investments segment.